Ainhoa Hernandez

Catalan Institute of Oncology

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Daniel Fuster

Associate Professor

University of Barcelona

SPAIN

View details

Pilar Navarro

Cientifico Titular-Head of the " Cancer Molecular Targets" group

SPAIN

View details

Carmen Balaña

Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

SPAIN

View details

Marta Domenech

Institut Català d'Oncologia

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ainhoa Hernandez

Research Interests

Explore related searches

Contact this professor

Articles (10)

Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors

Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects

Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancer

Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer-COVID Lung Vaccine Study

In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma

Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics

Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment

Correlation between PD-L1 expression and <i>MET</i> gene amplification in patients with advanced non-small cell lung cancer and no other actionable oncogenic driver

Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma

Collaborators (4)

Daniel Fuster

Pilar Navarro

Carmen Balaña

Marta Domenech

Make your next move.

Ainhoa Hernandez

Research Interests

Explore related searches

Contact this professor

Articles (10)

Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors

Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects

Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancer

Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer-COVID Lung Vaccine Study

In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma

Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics

Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment

Correlation between PD-L1 expression and &lt;i&gt;MET&lt;/i&gt; gene amplification in patients with advanced non-small cell lung cancer and no other actionable oncogenic driver

Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma

Collaborators (4)

Daniel Fuster

Pilar Navarro

Carmen Balaña

Marta Domenech

Make your next move.

Correlation between PD-L1 expression and <i>MET</i> gene amplification in patients with advanced non-small cell lung cancer and no other actionable oncogenic driver